Log in to save to my catalogue

Relaxin and beta-estradiol modulate targeted matrix degradation in specific synovial joint fibrocart...

Relaxin and beta-estradiol modulate targeted matrix degradation in specific synovial joint fibrocart...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1779373

Relaxin and beta-estradiol modulate targeted matrix degradation in specific synovial joint fibrocartilages: progesterone prevents matrix loss

About this item

Full title

Relaxin and beta-estradiol modulate targeted matrix degradation in specific synovial joint fibrocartilages: progesterone prevents matrix loss

Publisher

England: National Library of Medicine - MEDLINE Abstracts

Journal title

Arthritis research & therapy, 2006-01, Vol.8 (4), p.R98-R98, Article R98

Language

English

Formats

Publication information

Publisher

England: National Library of Medicine - MEDLINE Abstracts

More information

Scope and Contents

Contents

Relaxin, a 6-kDa polypeptide hormone, is a potent mediator of matrix turnover and contributes to the loss of collagen and glycosaminoglycans (GAGs) from reproductive tissues, including the fibrocartilaginous pubic symphysis of several species. This effect is often potentiated by beta-estradiol. We postulated that relaxin and beta-estradiol might si...

Alternative Titles

Full title

Relaxin and beta-estradiol modulate targeted matrix degradation in specific synovial joint fibrocartilages: progesterone prevents matrix loss

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1779373

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1779373

Other Identifiers

ISSN

1478-6354

E-ISSN

1478-6362,1478-6354

DOI

10.1186/ar1978

How to access this item